Exact Sciences Sees FY Rev $2.83B >EXAS
Exact Sciences, A Cathie Wood Holding, Comes In Hot With Double-Digit Sales Growth
Exact Sciences Sees FY Rev $2.48B-$2.49B >EXAS
Cathie Wood's Biggest Holdings Are Tumbling, Including Tesla
All Major Indexes Post Losses As Nasdaq Loses Over 2%; This Networking Stock Pops To Buck The Trend
Exact Sciences, A Cathie Wood Darling, Skids Despite A Sixth Big Quarter
Exact Sciences, A Cathie Wood Darling, Just Reported A Sixth Big Sales Quarter
Exact Sciences 2Q Loss/Shr 45c >EXAS
Amicus Therapeutics Stock Sees Improving Market Leadership; Earns 81 RS Rating
This Cathie Wood Stock Is Outperforming Even Tesla
The Wild Ride That Has Sent Exact Sciences 216% Higher Since October
Peloton, Tesla, Intel, Winnebago, Dollar Tree, and More Stock Market Movers
Why Top 2% Stock Exact Sciences Is On An Eight-Month Hot Streak — And Nearing A Profit-Taking Zone
Illumina’s FTC Fight Could Reshape U.S. Merger Policy
Exact Sciences, Guardant Health Put Up Big Sales Beats As They Target The 'Most Preventable' Cancer
Exact Sciences Stock Gains as 'Doubts Turn to Exuberance'
Dow Jones Futures Fall Ahead Of Inflation Report; Airbnb Plunges On Guidance
Exact Sciences Sees FY Rev $2.38B-$2.42B >EXAS
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle
U.S. Orders Illumina to Divest Cancer Tester Grail
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.